COMPANY PROFILE // THE 014 REPORT

aTYR PHARMA INC

ATYR (Nasdaq)

Assembled from 4 government sources in 0.1 s

Built from public records at 2026-11-20 00:33 ET. Every figure links to its source. Flags and checks built 2026-11-19 21:19 ET. Sources

FLAGS · DISCLOSURE · SUMMARY

Missing or hidden

  • Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-06-08 and 1 more time (last 24 months).2026-06-08 · source
  • AmberLEI 529900ENQUXMC5EBKO36 registration status is LAPSED (last update 2021-07-15): the legal-entity record has not been renewed.2021-07-15 · source
  • InfoGLEIF: no direct parent reported; reporting exception reason NON_CONSOLIDATING.2026-11-19 · source

✓ SEC filings✓ LEI✓ State registrationpossible match✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration

No SAM registration, no IRS return, no website, no lobbying registration on record.

aTYR PHARMA INC is an SEC-registered operating company in biological products, (no diagnostic substances), incorporated in DE, based in San Diego, CA; listed as ATYR (Nasdaq).[source] It reported revenue of $190,000 for the fiscal year ended 2025-12-31.[source] It has filed 48 documents with the SEC in the last 12 months; the latest is Form 8-K, filed 2026-11-13.[source] Its largest institutional holders on 13F filings are FEDERATED HERMES, INC., VANGUARD CAPITAL MANAGEMENT LLC, Kalehua Capital Management LLC (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; LEI 529900ENQUXMC5EBKO36 registration status is LAPSED (last update 2021-07-15).[source]

0federal award recipients matched by name in USAspending
0lobbying filings name it as client
48SEC filings in the last 12 months
$17.0Mheld by its 10 largest 13F holders (as of 2026-06-30)
SEC filings by month, 24 months
2024-12: 52025-01: 42025-02: 32025-03: 62025-04: 02025-05: 102025-06: 02025-07: 22025-08: 82025-09: 12025-10: 22025-11: 22025-12: 12026-01: 32026-02: 32026-03: 72026-04: 02026-05: 102026-06: 32026-07: 32026-08: 52026-09: 22026-10: 52026-11: 62024-122026-11
Flags by level
  • red0
  • amber2
  • info1
Largest 13F holders, value as filed
  • FEDERATED HERMES, INC.$5.1M
  • VANGUARD CAPITAL MANAGEMENT LLC$2.3M
  • Kalehua Capital Management LLC$2.1M
  • AQR CAPITAL MANAGEMENT LLC$1.6M
  • FMR LLC$1.5M
  • BlackRock, Inc.$1.1M
  • JANE STREET GROUP, LLC$1.0M
  • UBS Group AG$914K

RECORD · WEB

Ask about this entity

Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).

PEOPLE · COUNSEL · LINKS

Leadership, advisers and links

aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases. (Wikipedia, CC BY-SA 4.0)

Officers and directors (Forms 3, 4, 5)

As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.

Legal counsel, as publicly named

Links

  • Official website (Wikidata or the SEC record)
  • Wikipedia
  • Wikidata

EVERY LIST AND SOURCE · DATED

Checked and clear

26 lists and sources checked: 24 CLEAR, 2 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.

List or sourceResultCheckedWhat matched
OFAC SDN (Treasury)CLEAR2026-11-18
SAM.gov exclusionsCLEAR2026-11-19
HHS-OIG LEIECLEAR2026-11-13
FARA registrants (DOJ)CLEAR2026-11-19
Regulated facility: compliance, penalties and TRI parent (EPA)POSSIBLE MATCH2026-11-18ATYR PHARMA INC; ATYR PHARMA INC
Hazardous-waste handler facility (EPA RCRAInfo, sample)POSSIBLE MATCH2026-11-18ATYR PHARMA INC
Consumer complaints about a company (CFPB)CLEAR2026-11-18
Corporate enforcement action (DOJ, SEC, CFTC, EPA)CLEAR2026-11-18
SEC litigation release (respondent)CLEAR2026-11-18
Federal Reserve Board enforcement action (press release, 2022 onward)CLEAR2026-11-18
Enforcement order against a savings association (OCC, OTS archive to 2011)CLEAR2026-11-18
State environmental enforcement actions (Maryland MDE, Connecticut DEEP)CLEAR2026-11-18
Firm sanctioned or debarred by the IDB Group (incl. cross-debarments by WBG, ADB, EBRD, AfDB as listed by the IDB)CLEAR2026-11-18
UK sanctions designation (FCDO UK Sanctions List)CLEAR2026-11-18
US export screening list party (Consolidated Screening List, ITA)CLEAR2026-11-18
FDA recallCLEAR2026-11-18
FDA import alert or listed firm (Red / Yellow / Green list)CLEAR2026-11-18
Consumer product recall or recalling firm (CPSC, full history)CLEAR2026-11-18
Consumer product recall (CPSC)CLEAR2026-11-18
Vehicle recall, defect investigation or manufacturer (NHTSA ODI)CLEAR2026-11-18
Vehicle recall (NHTSA)CLEAR2026-11-18
FinCEN enforcement action (civil money penalty or consent order, 1999 onward)CLEAR2026-11-18
Union representation election (NLRB)CLEAR2026-11-18
NYC summons against an organization, adjudicated at OATH (all city agencies)CLEAR2026-11-18
Data breach notice to a state Attorney GeneralCLEAR2026-11-18
Data breach notice (California Attorney General)CLEAR2026-11-18

EVERY IDENTIFIER · LINKED

ID crosswalk

IdentifierValueRecord
SEC CIK0001339970source
LEI529900ENQUXMC5EBKO36source
EIN20-3435077source
California SOS entity2007000867record
Business address (SEC)10240 SORRENTO VALLEY ROAD, SAN DIEGO, CA, 92121source

Does not exist in the records we hold: UEI, NY DOS ID, FDIC certificate.

EACH FEEDS WATCH

Dates coming up

PEERS BY SIC CODE

Industry context

SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.

#11 of 183
federal dollars
#13 of 183
lobbying filings
#126 of 183
SEC filings in 12 months
#21 of 183
flags

Peers, each with its 014

SHARED PEOPLE · SHARED ADDRESS

Network neighbours

Shared directors and officers

EVERY SOURCE · NEWEST FIRST

One timeline

170 earlier entries

RENDERED FROM THIS PAGE

Relationship graph

Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.

DATA MOTION // NEWEST FIRST

What changed

Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.

COUNTS FROM THIS PAGE

Relationships at a glance

10largest institutional holders (13F as filed)
0other entities in the GLEIF ownership tree (ID tier)
0awarding federal agencies
0hiring lobbying firms: possible match: matched by name only, not merged
PRICE · FILINGS · POSTS · NEWS

Market & news

Price
NASDAQ:ATYR The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
Open in
Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

Financials
Filed figures: published SEC values, each linked to its filing.
Official posts
Links to posts from the company's and agencies' verified accounts: not connected yet.
News
Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER

1. Identity

2confirmed members (SEC registrant + GLEIF ownership tree)
1legal entities (LEI) in the ownership tree
27dated filings and events

5 possible matches held apart, matched by name only, not counted above.

IdentifierValueHow it was resolvedSource
SEC CIK1339970id:sec-anchor: the SEC registrant record of this companySEC EDGAR
Ticker / exchangeATYR / NasdaqSEC company record: ticker and exchange as listed on the SEC company recordSEC EDGAR
LEI (root of the ownership tree)529900ENQUXMC5EBKO36id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 529900ENQUXMC5EBKO36)GLEIF
EIN203435077carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001339970SEC EDGAR / IRS
CUSIP002120202carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001339970SEC EDGAR

possible match: matched by name only, not merged (2)

Identifiers carried by records that share the company's exact name. Not merged into the identity above.

IdentifierValueHow it was resolvedSource
EPA FRS id110071455004 (ATYR PHARMA INC)name-exact:legal-name: same registered legal name as 'aTYR PHARMA INC'EPA ECHO facilities
EPA FRS id110059750899 (ATYR PHARMA INC)name-exact:legal-name: same registered legal name as 'aTYR PHARMA INC'EPA ECHO facilities
AS FILED · EACH WITH ITS DATE AND FILING

2. Filed figures

Key figures (annual filing)

FigureValuePeriod or as ofSourceBasisRetrievedReport
Revenue (fiscal year ended 2025-12-31)$190,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTaxas filed2026-11-20 05:33 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)-$74,118,0002025-12-3110-K, XBRL NetIncomeLossas filed2026-11-20 05:33 UTCReport an error
Total assets (at 2025-12-31)$93,003,0002025-12-3110-K, XBRL Assetsas filed2026-11-20 05:33 UTCReport an error
Stockholders' equity (at 2025-12-31)$67,480,0002025-12-3110-K, XBRL StockholdersEquityas filed2026-11-20 05:33 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$10,743,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValueas filed2026-11-20 05:33 UTCReport an error

Company profile facts (SEC)

FigureValuePeriod or as ofSourceBasisRetrievedReport
SEC entity typeoperating2026-11-13SEC EDGAR company profileas filed2026-11-20 05:33 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-13SEC EDGAR company profileas filed2026-11-20 05:33 UTCReport an error
State of incorporationDE2026-11-13SEC EDGAR company profileas filed2026-11-20 05:33 UTCReport an error
Fiscal year end (MMDD)12312026-11-13SEC EDGAR company profileas filed2026-11-20 05:33 UTCReport an error
Business address10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 921212026-11-13SEC EDGAR company profileas filed2026-11-20 05:33 UTCReport an error
ExchangesNasdaq2026-11-13SEC EDGAR company profileas filed2026-11-20 05:33 UTCReport an error

Other filed values

FigureValuePeriod or as ofSourceBasisRetrievedReport
Operating cash flow (fiscal year ended 2025-12-31)-$61,986,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivitiesas filed2026-11-20 05:33 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$77,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipmentas filed2026-11-20 05:33 UTCReport an error
Operating lease liabilities (at 2025-12-31)$11,144,0002025-12-3110-K, XBRL OperatingLeaseLiabilityas filed2026-11-20 05:33 UTCReport an error
Form D total offering amount (D filed 2017-09-15)$45,849,9822017-09-15Das filed2026-11-20 05:33 UTCReport an error
Form D total amount sold (D filed 2017-09-15)$45,849,9822017-09-15Das filed2026-11-20 05:33 UTCReport an error
Form D industry groupBiotechnology2017-09-15Das filed2026-11-20 05:33 UTCReport an error
Form D revenue rangeDecline to Disclose2017-09-15Das filed2026-11-20 05:33 UTCReport an error
Form D date of first sale2017-08-312017-09-15Das filed2026-11-20 05:33 UTCReport an error
Plan (pension, plan no. 001)ATYR PHARMA, INC. 401(K) PLAN: 85 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)as filed2026-11-20 05:33 UTCReport an error

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-06 · accession 0001339970-26-000081

ItemValuePeriodFormFiledAccessionRetrievedReport
Revenue$03 months ended 2026-09-3010-Q2026-11-060001339970-26-0000812026-11-20 05:33 UTCReport an error
Net income (loss)-$18,261,0003 months ended 2026-09-3010-Q2026-11-060001339970-26-0000812026-11-20 05:33 UTCReport an error
Cash and cash equivalents$13,140,000at 2026-09-3010-Q2026-11-060001339970-26-0000812026-11-20 05:33 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.

No estimates: every value is as filed and links to the filing it came from.

Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.

NEWEST FIRST · EACH LINKS TO ITS FILING

3. Registration and filing timeline

2 earlier entries

8-K item text, as filed (excerpts)

Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.

POSSIBLE MATCHES · GROUPED BY SOURCE

8. Enforcement by agency

EPA ECHO facilities (2)

possible match: matched by name only, not merged (2)

Possible match based on name, not a shared identifier. Compare the records.

EPA RCRA hazardous waste (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.

AS FILED · LARGEST HOLDERS

10. 13F institutional holders

RankHolder (13F filer)Value heldAs ofSourceRetrievedReport
1FEDERATED HERMES, INC.$5,078,5762026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
2VANGUARD CAPITAL MANAGEMENT LLC$2,273,4302026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
3Kalehua Capital Management LLC$2,134,3562026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
4AQR CAPITAL MANAGEMENT LLC$1,557,9752026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
5FMR LLC$1,474,9422026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
6BlackRock, Inc.$1,090,5522026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
7JANE STREET GROUP, LLC$1,027,2702026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
8UBS Group AG$914,0972026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
9TWO SIGMA INVESTMENTS, LP$743,1042026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error
10CITADEL ADVISORS LLC$741,2652026-06-30SEC 13F filing2026-11-20 05:33 UTCReport an error

13F as filed: the holder's own report of its position value at the quarter end.

GLEIF OWNERSHIP TREE · ID TIER

11. Subsidiaries

1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).

Exhibit 21 subsidiaries: not held yet.

POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS

13. Permits and local records

2 state and city records carry this company's exact name, from 2 sources. Possible matches only.

California business registrations (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

ClinicalTrials.gov (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

WHAT THIS PAGE READ

Sources

As of 2026-11-20 (record built 2026-11-20T05:33:11Z). Sources used: SEC EDGAR, DOL EBSA Form 5500 public datasets, SEC 13F holdings, GLEIF.

Not checked: FTC enforcement actions; DOJ press releases (beyond FARA and the corporate enforcement set); federal and state court records; UCC filings, liens and bankruptcy dockets; IRS automatic revocation list; state annual-report dates; company formation dates (only where a state registry record states one).

JSON · MCP · API

API and agents

The same profile as JSON: GET /company/1339970.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001339970. Every source URL used is listed in the file.

Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.